Innovation Spirits
We have independently developed 10 minimally invasive interventional treatment solutions targeting tricuspid valve diseases, mitral valve diseases, aortic valve diseases, and heart failure. All products are based on our original innovation and possess global patents and independent intellectual property rights.

JensFlag is our self-developed innovative transcatheter mitral valve leaflet and delivery system designed to treat patients with severe mitral regurgitation, especially those caused by mitral valve prolapse.

JensFlag is made of cowhide and trimmed to size. JensFlag is a product under development for transcatheter mitral valves using leaflet augmentation technology.